Milk thistle (Silybum marianum) is one of the most extensively researched plants in liver science. The active compound complex silymarin, found in its fruits, has been evaluated in numerous clinical studies for its liver-protective, antioxidant and metabolic properties. Here is a factual overview of what the research actually shows, where the evidence is solid and where gaps remain – and why the combination with choline is particularly relevant.
The Plant and Its Active Compounds
Native to southern Europe, North Africa and western Asia, milk thistle has been used in traditional medicine across many cultures for centuries. As an annual or biennial plant, it reaches heights of 60 to 150 centimetres. Its dark green, white-veined leaves and purple flower heads are unmistakable.
The medicinally used part is the ripe fruit (Silybi marianae fructus). It contains the active compound complex silymarin – a mixture of flavonolignans making up approximately 1.5 to 3 percent of the fruit. The three main components are silybin (the most potent and best-studied), silydianin and silychristin.
Silymarin acts on several levels: it scavenges free radicals, raises levels of the liver's own antioxidant glutathione, stabilises liver cell membranes and stimulates regeneration of damaged liver cells. It also has anti-inflammatory and antifibrotic properties, meaning it may counteract scarring of liver tissue.
What the Evidence Shows
Non-Alcoholic Fatty Liver Disease (MASLD)
The strongest evidence for milk thistle relates to metabolic dysfunction-associated steatotic liver disease (MASLD), the most common chronic liver condition in industrialised countries. A 2024 meta-analysis (Malik et al., Canadian Liver Journal, DOI: 10.3138/canlivj-2023-0021) analysing nine clinical trials showed that silymarin significantly reduced liver enzymes ALT and AST and lowered triglycerides. A further 2024 meta-analysis (PROSPERO CRD42022335681) covering 27 studies with 1,691 participants confirmed that silymarin produced the strongest reductions in ALT and AST among the plant compounds studied.
Metabolism: Blood Sugar and Lipids
Several systematic reviews indicate that silymarin also affects metabolic markers. A meta-analysis of seven studies involving 370 patients found significant reductions in fasting blood glucose and long-term blood sugar (HbA1c). A further analysis of 16 studies with 1,358 patients confirmed these effects and additionally showed reductions in total cholesterol and LDL.
Death Cap Mushroom Poisoning
The most clinically established application of silybin is emergency treatment for poisoning by the death cap mushroom (Amanita phalloides). Administered intravenously, silybin blocks the transport mechanisms at the liver cell membrane through which the mushroom toxin enters cells. This application is part of standard intensive care therapy.
Areas with Limited Evidence
For alcoholic liver disease, well-designed clinical trials are lacking – efficacy here remains unclear. For viral hepatitis, the picture is mixed: in hepatitis C, milk thistle is well tolerated but shows no clinically relevant benefit according to meta-analysis. For traditional applications such as digestive complaints, evidence is mainly based on longstanding traditional use rather than controlled trials.
Silymarin and Choline – A Meaningful Combination
One approach particularly relevant for food supplements is combining milk thistle extract with choline. Choline is an essential nutrient for which the European Food Safety Authority (EFSA) has authorised the following health claim: "Choline contributes to the maintenance of normal liver function." Milk thistle and choline target different mechanisms – silymarin protects liver cells through antioxidant and regenerative action, while choline supports fat metabolism in the liver. The two complement each other effectively.
Leber essentia by Natura Nova
Leber essentia combines standardised milk thistle extract with choline – a nutrient that contributes to the maintenance of normal liver function. Manufactured in Switzerland to GMP standards, laboratory-tested.
Forms of Administration
| Form | Properties | Typical Use |
|---|---|---|
| Tea (crushed fruits) | Low silymarin content; traditional use for mild digestive complaints | 3–4 g fruit, 150 ml hot water, steep 10–15 min, 3× daily |
| Food supplement (capsules) | Defined silymarin content, often combined with choline; for daily support | As directed, typically 1–2 capsules daily |
| Medicinal product (capsules/tablets) | Highly standardised extracts (70–80% silymarin); for therapeutic use | 200–400 mg silymarin daily, as prescribed |
| Infusion (silybin i.v.) | Intensive care use only, for mushroom poisoning | Medical dosing |
Dosage and Safety
Milk thistle is generally well tolerated at therapeutic doses. Mild gastrointestinal complaints or a slight laxative effect may occasionally occur. Hypersensitivity reactions are very rare.
Contraindications: People with allergies to plants in the daisy family (chamomile, arnica, calendula) should avoid milk thistle. Use is not recommended during pregnancy and breastfeeding, or in children and adolescents under 18. Women with hormone-sensitive conditions (breast, uterine or ovarian cancer, endometriosis) should not use preparations made from the aerial parts of the plant.
Interactions: Silymarin may enhance the blood sugar-lowering effect of antidiabetic medications and may increase INR in people taking anticoagulants such as warfarin. Interactions with protease inhibitors (e.g. indinavir) and sirolimus have been reported. Consult a healthcare professional if in doubt.
Conclusion
Milk thistle is one of the most thoroughly researched plants in liver science. For non-alcoholic fatty liver disease, meta-analyses show measurable effects on liver enzymes, blood lipids and blood sugar. In emergency medicine for death cap mushroom poisoning, silybin is indispensable. For other applications, clinical evidence remains incomplete. For daily liver health support, high-quality food supplements – particularly those combining milk thistle with choline – offer a scientifically grounded approach.
This article is for general information purposes only and does not replace medical advice. Food supplements are not a substitute for a varied and balanced diet.
References
- Malik A et al. (2024). Effects of silymarin use on liver enzymes and metabolic factors in MASLD. Canadian Liver Journal, 7(1), 40–53. DOI: 10.3138/canlivj-2023-0021
- Meta-analysis Curcumin/Resveratrol/Silymarin in MASLD (2024). PROSPERO CRD42022335681. PMC11666838
- Alqarni et al. (2025). Silybum marianum meta-analysis on liver injury. BMC Complementary Medicine. PMC11992775
- EFSA Health Claim Choline / Liver function: efsa.europa.eu
